1. Home
  2. AMRX vs RNW Comparison

AMRX vs RNW Comparison

Compare AMRX & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • RNW
  • Stock Information
  • Founded
  • AMRX 2002
  • RNW 2011
  • Country
  • AMRX United States
  • RNW United Kingdom
  • Employees
  • AMRX N/A
  • RNW N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • RNW Electric Utilities: Central
  • Sector
  • AMRX Health Care
  • RNW Utilities
  • Exchange
  • AMRX Nasdaq
  • RNW Nasdaq
  • Market Cap
  • AMRX 2.5B
  • RNW 2.4B
  • IPO Year
  • AMRX N/A
  • RNW N/A
  • Fundamental
  • Price
  • AMRX $8.23
  • RNW $6.84
  • Analyst Decision
  • AMRX Strong Buy
  • RNW Strong Buy
  • Analyst Count
  • AMRX 4
  • RNW 1
  • Target Price
  • AMRX $11.50
  • RNW $7.50
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • RNW 886.3K
  • Earning Date
  • AMRX 08-08-2025
  • RNW 06-16-2025
  • Dividend Yield
  • AMRX N/A
  • RNW N/A
  • EPS Growth
  • AMRX N/A
  • RNW 16.07
  • EPS
  • AMRX N/A
  • RNW 0.13
  • Revenue
  • AMRX $2,830,186,000.00
  • RNW $1,135,947,896.00
  • Revenue This Year
  • AMRX $9.84
  • RNW N/A
  • Revenue Next Year
  • AMRX $7.33
  • RNW $17.72
  • P/E Ratio
  • AMRX N/A
  • RNW $54.07
  • Revenue Growth
  • AMRX 13.42
  • RNW 19.36
  • 52 Week Low
  • AMRX $6.32
  • RNW $5.15
  • 52 Week High
  • AMRX $9.48
  • RNW $7.49
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 61.71
  • RNW 56.00
  • Support Level
  • AMRX $8.05
  • RNW $6.47
  • Resistance Level
  • AMRX $8.24
  • RNW $6.94
  • Average True Range (ATR)
  • AMRX 0.21
  • RNW 0.20
  • MACD
  • AMRX 0.03
  • RNW 0.00
  • Stochastic Oscillator
  • AMRX 90.91
  • RNW 65.00

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: